BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 34777387)

  • 1. Mechanisms of Immune Checkpoint Inhibitor-Mediated Colitis.
    Westdorp H; Sweep MWD; Gorris MAJ; Hoentjen F; Boers-Sonderen MJ; van der Post RS; van den Heuvel MM; Piet B; Boleij A; Bloemendal HJ; de Vries IJM
    Front Immunol; 2021; 12():768957. PubMed ID: 34777387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the Gut Microbiome to Mitigate Immunotherapy-Induced Colitis in Cancer.
    Chang AE; Golob JL; Schmidt TM; Peltier DC; Lao CD; Tewari M
    Trends Cancer; 2021 Jul; 7(7):583-593. PubMed ID: 33741313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.
    Hayase E; Jenq RR
    Genome Med; 2021 Jun; 13(1):107. PubMed ID: 34162429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of characteristic subepithelial surface granulomatosis in immune-related adverse event-associated enterocolitis.
    Kubo T; Hirohashi Y; Keira Y; Akimoto M; Ikeda T; Kikuchi N; Iwaki H; Kikuchi T; Obata M; Morita R; Kasai K; Segawa K; Tsukahara T; Kanaseki T; Murata K; Kikuchi Y; Shinkawa T; Hasegawa T; Torigoe T
    Cancer Sci; 2021 Mar; 112(3):1320-1325. PubMed ID: 33459466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multifaceted roles of common gut microbiota in immune checkpoint inhibitor-mediated colitis: From mechanism to clinical application.
    Han X; Zang D; Liu D; Chen J
    Front Immunol; 2022; 13():988849. PubMed ID: 36189293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-Gamma-Producing CD8
    Sasson SC; Slevin SM; Cheung VTF; Nassiri I; Olsson-Brown A; Fryer E; Ferreira RC; Trzupek D; Gupta T; Al-Hillawi L; Issaias ML; Easton A; Campo L; FitzPatrick MEB; Adams J; Chitnis M; Protheroe A; Tuthill M; Coupe N; Simmons A; Payne M; Middleton MR; Travis SPL; ; Fairfax BP; Klenerman P; Brain O
    Gastroenterology; 2021 Oct; 161(4):1229-1244.e9. PubMed ID: 34147519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis.
    Mann JE; Lucca L; Austin MR; Merkin RD; Robert ME; Al Bawardy B; Raddassi K; Aizenbud L; Joshi NS; Hafler DA; Abraham C; Herold KC; Kluger HM
    J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis.
    Hone Lopez S; Kats-Ugurlu G; Renken RJ; Buikema HJ; de Groot MR; Visschedijk MC; Dijkstra G; Jalving M; de Haan JJ
    Virchows Arch; 2021 Dec; 479(6):1119-1129. PubMed ID: 34338882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.
    Haryal A; Townsend MJ; Baskaran V; Srivoleti P; Giobbie-Hurder A; Sack JS; Isidro RA; LeBoeuf NR; Buchbinder EI; Hodi FS; Grover S
    Cancer; 2023 Feb; 129(3):367-375. PubMed ID: 36377339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between gut microbiota and immune checkpoint inhibitor-related colitis.
    Zhou G; Zhang N; Meng K; Pan F
    Front Immunol; 2022; 13():1001623. PubMed ID: 36389768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite.
    Renga G; Nunzi E; Pariano M; Puccetti M; Bellet MM; Pieraccini G; D'Onofrio F; Santarelli I; Stincardini C; Aversa F; Riuzzi F; Antognelli C; Gargaro M; Bereshchenko O; Ricci M; Giovagnoli S; Romani L; Costantini C
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35236743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal mucosal toxicities from immune checkpoint inhibitors: Current understanding and future directions.
    Dougan M
    Immunol Rev; 2023 Sep; 318(1):11-21. PubMed ID: 37455375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal inflammation predicts response to systemic steroids in immune checkpoint inhibitor colitis.
    Mooradian MJ; Wang DY; Coromilas A; Lumish M; Chen T; Giobbie-Hurder A; Johnson DB; Sullivan RJ; Dougan M
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32414860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint inhibitor-mediated colitis is associated with cancer overall survival.
    Weingarden AR; Gubatan J; Singh S; Balabanis TC; Patel A; Sharma A; Habtezion A
    World J Gastroenterol; 2022 Oct; 28(39):5750-5763. PubMed ID: 36338892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota shed new light on the management of immune-related adverse events.
    Tan B; Liu YX; Tang H; Chen D; Xu Y; Chen MJ; Li Y; Wang MZ; Qian JM
    Thorac Cancer; 2022 Oct; 13(19):2681-2691. PubMed ID: 36043345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota: A potential target for enhancing the antitumor efficacy and reducing the toxicity of immune checkpoint inhibitors.
    Luo B; Zhang Y; Zhang C; Liu X; Shi C
    Cancer Lett; 2021 Jul; 509():53-62. PubMed ID: 33845122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colitis following the use of immune checkpoint inhibitors: A real-world analysis of spontaneous reports submitted to the FDA adverse event reporting system.
    Hu Y; Gong J; Zhang L; Li X; Li X; Zhao B; Hai X
    Int Immunopharmacol; 2020 Jul; 84():106601. PubMed ID: 32422528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th9 Cells: Probable players in ulcerative colitis pathogenesis.
    Shohan M; Elahi S; Shirzad H; Rafieian-Kopaei M; Bagheri N; Soltani E
    Int Rev Immunol; 2018; 37(4):192-205. PubMed ID: 29672174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Checkpoint Inhibitor-associated Diarrhea and Colitis: A Systematic Review and Meta-analysis of Observational Studies.
    Tran AN; Wang M; Hundt M; Chugh R; Ohm J; Grimshaw A; Ciarleglio M; Hung KW; Proctor DD; Price CC; Laine L; Al-Bawardy B
    J Immunother; 2021 Oct; 44(8):325-334. PubMed ID: 34380976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.